{"lang": "en", "conversation_id": "1277559463889813505", "context_annotations": [{"domain": {"id": "123", "name": "Ongoing News Story", "description": "Ongoing News Stories like 'Brexit'"}, "entity": {"id": "1220701888179359745", "name": "COVID-19"}}, {"domain": {"id": "47", "name": "Brand", "description": "Brands and Companies"}, "entity": {"id": "10029237524", "name": "The Wall Street Journal"}}, {"domain": {"id": "29", "name": "Events [Entity Service]", "description": "Entity Service related Events domain"}, "entity": {"id": "1263485418844024832", "name": "COVID-19: Global updates ", "description": "The latest news and analysis on the coronavirus pandemic from around the world."}}], "reply_settings": "everyone", "public_metrics": {"retweet_count": 278, "reply_count": 126, "like_count": 287, "quote_count": 246}, "source": "SocialFlow", "entities": {"urls": [{"start": 112, "end": 135, "url": "https://t.co/CMmXHdn1cg", "expanded_url": "https://on.wsj.com/31sj0hW", "display_url": "on.wsj.com/31sj0hW"}], "annotations": [{"start": 73, "end": 76, "probability": 0.7084, "type": "Place", "normalized_text": "U.S."}]}, "id": "1277559463889813505", "text": "Gilead's Covid-19 drug remdesivir will be priced at $3,120 for a typical U.S. patient with commercial insurance https://t.co/CMmXHdn1cg", "author_id": "3108351", "possibly_sensitive": false, "created_at": "2020-06-29T11:08:06.000Z"}